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The mammalian target of rapamycin (mTOR) serine/threonine kinase plays a central role in insulin signaling
and cell growth, through two distinct complexes with its subunits raptor or rictor. In this issue, two reports
utilizing tissue-specific knockout mice detail key roles for mTORC1 in skeletal muscle and adipose tissue
function.The mammalian target of rapamycin
(mTOR) is a central regulator of cell growth
in all eukaryotes. mTOR integrates envi-
ronmental cues including growth factors
and nutrients through a number of inter-
secting pathways that have been exten-
sively decoded in the past decade (Wulls-
chleger et al., 2006). Across eukaryotes,
TOR assembles into two biochemically
and functionally distinctmultiprotein com-
plexes. Inmammals, themTORcomplex 1
(mTORC1) is composed of four known
subunits: raptor (regulatory associated
protein of mTOR), PRAS40, mLST8, and
mTOR. The mTORC2 complex contains
rictor (rapamycin insensitive companion
of mTOR), mSIN1, PRR5/Protor, mLST8,
and mTOR (Guertin and Sabatini, 2007).
Mouse embryos lacking mTOR or its key
mTORC1 subunit raptor die early in devel-
opment around the time of implantation
(e5.5) (Guertin et al., 2006). Mice lacking
mTORC2 subunit rictor or the common
subunitmLST8 die atmidgestation (e10.5)
with vascular defects (Guertin et al., 2006;
Shiota et al., 2006). Using tissue-specific
deletion of the unique complex subunits
raptor and rictor, two papers in this issue
of Cell Metabolism examine the require-
ment for mTORC1 and/or mTORC2 in
skeletal muscle (Bentzinger et al., 2008)
and the requirement for mTORC1 activity
in adipocytes (Polak et al., 2008).
Signaling frommTORC1 is nutrient sen-
sitive, acutely inhibited by the bacterial
macrolide rapamycin, and controls cell
growth, angiogenesis, and metabolism.
The best-known substrates of mTORC1
are the translational regulators 4EBP1
and ribosomal S6 kinase (S6K1). In con-
trast, mTORC2 is not sensitive to nutrients
nor acutely inhibited by rapamycin, and its
known substrates include the hydropho-
bic motif phosphorylation (‘‘PDK2’’) sites
in AGC kinases including Akt and PKCfamily members (Guertin and Sabatini,
2007). One of the key activators of the
mTORC1 pathway is the PI3-kinase path-
way, which plays a key role in promoting
cell growth and insulin-mediated effects
on metabolism. Conversely, the AMPK
pathway suppresses mTORC1 and in-
hibits cell growthwhen nutrient conditions
are limited and also plays key roles in glu-
cose and lipid metabolism. Consistent
with its dependence on growth factor
and nutrient cues, mTORC1 hyperactiva-
tion is observed in a large number of can-
cers, as well as in key peripheral meta-
bolic tissues in animals on a high-fat diet.
The study here from a collaborative
effort between the Hall lab and the Ruegg
lab examines a skeletal muscle-specific
knockout of raptor, or rictor, or both. The
muscle-specific loss of rictor has minimal
impact on muscle physiology. In contrast,
the mice lacking raptor in skeletal muscle
exhibit progressive muscle degeneration,
culminating in premature death between
4 and 7 months of age. The greatest de-
fects were observed in the slow-twitch
oxidative muscles such as the soleus and
the diaphragm. Raptor-deficient soleus
muscle from older mice exhibited a severe
loss in the number of mitochondria, which
was paralleled by an increase in glycogen
content.Lossof raptorcauseddramatically
increasedexpressionofslowmyosinheavy
chain and troponin in both slow- and fast-
twitch muscle, which may be due to the
observed increase in the myogenic tran-
scription factor MEF2A. Indeed, functional
assays revealed that the raptor-deficient
muscleexhibited reducedaerobiccapacity
like fast-twitch fibers but contractile prop-
erties similar to slow-twitch oxidative mus-
cle fibers. Consistent with these signs of
dystrophy, the raptor muscle knockout
(KO) mice performed only 60% as much
voluntary wheel running as control mice.Cell Metabolism 8,Analysis of signaling downstream of
mTORC1 and mTORC2 in soleus muscle
reveals similarities with other cell types
examined upon suppression of raptor or
rictor, with some key distinctions. Dele-
tion of raptor resulted in near complete
loss of phosphorylation of mTORC1 sub-
strates S6K and 4EBP1 with a dramatic
increase in IRS-1 protein and Akt phos-
phorylation. Indeed, functional increases
in Akt signalingwere observed, consistent
with the well-documented suppression of
PI3K-Akt signaling downstream of mTOR
C1 via downregulation of IRS proteins
(Harrington et al., 2005).
In rictor-deficient muscle, phosphoryla-
tion of the hydrophobic motif sites in Akt
and PKCa were greatly reduced, consis-
tent with these sites being dependent on
mTORC2 activity (Guertin and Sabatini,
2007). As observed previously, Akt signal-
ing tomTORC1 is largely unaffected in ric-
tor-deficient muscle (Kumar et al., 2008).
However, muscle deficient for both raptor
and rictor exhibited elevated Akt473
phosphorylation, similar to the raptor
knockout alone (Bentzinger et al., 2008).
These unexpected findings suggest that
a kinase other than mTORC2 can phos-
phorylate Akt473 in skeletal muscle and
that this kinase is upregulated when rap-
tor is deficient. It will be interesting to
identify the kinase responsible for this al-
ternate muscle-‘‘PDK2’’ activity and also
to define under what physiological and
pathological states mTORC2 and the
mystery kinase contribute to the regula-
tion of Akt signaling.
In the accompanying study, theHall and
Ruegg labs examine the requirement for
mTORC1 in adipogenesis (Polak et al.,
2008). The authors first repeat previous
findings indicating that mTORC1 is re-
quired for adipogenesis in cell culture
models and then further show that lossNovember 5, 2008 ª2008 Elsevier Inc. 343
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Previewsof mTORC1 in mature adipocytes results
in loss of triglycerides. To examine this
in vivo, raptor was deleted in mature adi-
pocytes, resulting in lean mice with a re-
duction in both adipocyte size and num-
ber. As seen in other lean mouse models,
raptor adipose KO mice are resistant to
diet-induced obesity and exhibit insulin
hypersensitivity with improved glucose
tolerance. The insulin sensitivity is due to
increased insulin signaling in both adipose
tissue and skeletal muscle. As observed in
the mice lacking raptor in skeletal muscle,
elevated insulin signaling through Akt in
adipose tissue appears to be due to loss
of the mTORC1 negative feedback loop
on IRS-1/PI3K/Akt, paralleling previous
findings from muscle and adipose tissue
in whole-body S6K1 knockout mice on
a high-fat diet (Um et al., 2004).
One molecular basis underlying the
leanness of the mice appears to be ele-
vated energy expenditure, which may be
a consequence of increased mitochon-
drial uncoupling from a 25-fold elevated
level of UCP1 mRNA expression in rap-
tor-deleted white adipose tissue (WAT).
In contrast to adipose tissue, decreases
in PGC1a mRNA were observed in the
raptor-deficient muscle, consistent with
a previous study in C2C12 and mouse
embryonic fibroblasts demonstrating
that inhibition of mTORC1 reduces
PGC1a mRNA through regulation of the
YY-1 transcription factor (CunninghamRegulating the Mo
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Insulin-triggered trafficking of GLUT
membrane are mechanical processe
movement. Now, Yip et al. (2008) lin
phosphorylation of this critical moto
Insulin signaling in its target tissues of
fat and muscle is known to lead to the
exocytosis of vesicles loaded with the
344 Cell Metabolism 8, November 5, 2008 ªet al., 2007). Other possible downstream
effectors for mTORC1 in the control of
muscle and adipose metabolism not ex-
plored in these studies are the key lipo-
genic transcription factor Srebp-1 and
the lipodystrophy protein lipin, both of
which have been previously shown to be
regulated by mTORC1 (Porstmann et al.,
2008; Huffman et al., 2002). Another
well-described function for mTORC1 is
in suppressing autophagy, and future
studies will be needed to define any role
for autophagy in the observed pheno-
types reported here, as well as to further
illuminate the precise downstream effec-
tors of mTORC1 mediating control of
metabolism, tissue homeostasis, and dif-
ferentiation in different tissues.
Taken together, these studies define
critical roles for mTORC1 in metabolic
control in adipose tissue as well as mus-
cle homeostasis. Given that rapamycin
analogs are being examined for the treat-
ment of a host of diseases ranging from
cancer to neurological disease to facets
of metabolic syndrome itself, further dis-
section of the roles of mTORC1 and
mTORC2 in different tissues will provide
future insights into the therapeutic prom-
ise this pathway holds.
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s and their fusion with the plasma
at coordinate and facilitate vesicle
emonstrating direct CaMKII-driven
for researchers is to link early signaling
to the vesicle-trafficking machinery. Early
events in insulin signaling include the
